IRCT138904084272N1已完成2 期
Clinical trial of IMOD in HIV/AIDS patients
Pars Roos Biotechnology Co.0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •Diagnosis of HIV infection (two positive ELISA confirmed by one positive Western Blot test)
- •Receiving HAART
- •Age more than 18-75
- •Exclusion criteria
- •Evidence of malignancy (diagnosed or presenting a sign or symptom of major cancer such as hemoptysis, chronic cough, rectal bleeding, etc) except for Kaposi’s sarcoma
- •Presence of life threatening conditions such as hepatic or renal failure or congestive heart failure
- •Presence of life threatening infections or other serious and dangerous infections
- •Presence of liver function disorders in laboratory tests including elevation of liver enzymes or Bilirubin level more than 3 times of the upper limit of the normal range
- •Drug and alcohol abuse (more than 21 units alcohol for males and 14 units for females)
- •Treatment with corticosteroids, immune suppressants, radiotherapy or chemotherapy
- •Any known drug hypersensitivity
- •Inability or refusal to sign the informed consent
- •Receiving any investigational drug within 30 days prior to screening
- •Pregnancy or intention of becoming pregnant during the study period
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Clinical investigation of HIV infection diagnostic kitHIV infectionJPRN-UMIN000021201Keio University School of Medicine Center for Infectious Disease and Infection Control200
暂停
不适用
HAART followed by maintenance with monotherapy-Kaletra (MAIMOKA).HIV/AIDSNL-OMON20599VU Medical CenterandUniversity Medical Center Utrecht240
尚未招募
1 期
Study for prevention and treatment of AIDS patients with incomplete immune function reconstruction (liver and kidney essence deficiency syndrome) by kidney tonifying and medullatingITMCTR1900002485Hubei Provincial Hospital of Traditional Chinese Medicine
已完成
3 期
A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-DideoxyinosineAIDS-Related ComplexAcquired Immunodeficiency SyndromeNCT00001267National Cancer Institute (NCI)42
进行中（未招募）
不适用
An open-label trial of TMC125 in HIV-1 infected subjects who were randomized to an active control arm of any sponsor-selected TMC125 trial and either virologically failed or completed the entire treatment period. - N/AHIV-1 infectionEUCTR2004-001658-10-ESTibotec Pharmaceuticals Limited60